Ask AI
ProCE Banner Activity

Considerations for PrEP in Transgender Persons

Clinical Thought
Important considerations for PrEP in transgender individuals include choosing the right PrEP option and addressing stigma to improve adherence.

Released: April 15, 2022

Share

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Head of Infectious Diseases Department
St Antoine Hospital, AP-HP
Sorbonne University
Paris, France

Karine Lacombe, MD, PhD, has disclosed that she has received consulting fees from Gilead Sciences, GlaxoSmithKline, Janssen, and MSD.